Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Axcel VI and Currentum in connection with the acquisition of Holmströms Rör
Mandate

Vinge advises Axcel VI and Currentum in connection with the acquisition of Holmströms Rör

November 22, 2022 M&A Banking and Finance Real Estate and Construction Employment and Benefits

Vinge advises Axcel VI and the Currentum Group in connection with the acquisitions of Holmströms Rör AB, Holmströms Rör i Ängelholm AB and Holmströms Rör Syd Väst AB.

The companies provide installation and services within heating and sanitation and are based in Skåne. Together, the companies have a turnover of approximately SEK 192 million and approximately 70 employees.

Vinge’s team consisted of partner Christina Kokko together with Karl Klackenberg, Carl Fredrik Wachtmeister and Egil Svensson (M&A), Daniel Prawitz (Construction), Elin Broman (Employment), Calle Tengwall Pagels (Financing), Frida Ställborn (Real Estate) and Anna Ekdahl Roos (project assistant).

 

Related

Vinge advises Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of Bizware

 Vinge has advised the Nordic private equity firm Intera Partners’ portfolio company Yellow Elk in connection with its acquisition of the data analytics and AI firm Bizware AB and its subsidiaries Bizware Lead AB and Bizware Nova AB.
September 11, 2025

Vinge has acted as local counsel supporting lead counsel Latham & Watkins in advising Cadence in connection with its acquisition of Hexagon’s Design & Engineering Business for approx. EUR 2.7 billion

 Cadence (Nasdaq: CDNS) announced it has entered into a definitive agreement to acquire the Design & Engineering business of Hexagon AB, which includes its MSC Software business—a pioneer in engineering simulation and analysis solutions.
September 09, 2025

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025